|
SH3KBP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.65234492754962E-12 |
| Normal-vs-Stage2 |
3.5457000000072E-05 |
| Normal-vs-Stage3 |
7.87603315899332E-12 |
| Normal-vs-Stage4 |
1.25190000033193E-07 |
| Stage1-vs-Stage2 |
9.861400E-01 |
| Stage1-vs-Stage3 |
4.780600E-01 |
| Stage1-vs-Stage4 |
3.681500E-02 |
| Stage2-vs-Stage3 |
6.732000E-01 |
| Stage2-vs-Stage4 |
8.318300E-02 |
| Stage3-vs-Stage4 |
9.450400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
4.789100E-04 |
| Normal-vs-Asian |
3.539500E-02 |
| Caucasian-vs-AfricanAmerican |
1.425360E-01 |
| Caucasian-vs-Asian |
5.278000E-01 |
| AfricanAmerican-vs-Asian |
2.496400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
5.03397323825538E-12 |
| Male-vs-Female |
4.836600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.22689999999082E-05 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
3.46411788143541E-12 |
| Normal-vs-Age(81-100Yrs) |
4.003700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.846000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.268390E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.530300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.315440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.118360E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.419400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.627000E-04 |
| Normal-vs-Grade 2 |
1.7178480860025E-12 |
| Normal-vs-Grade 3 |
2.09454675825782E-12 |
| Normal-vs-Grade 4 |
7.84529996522565E-09 |
| Grade 1-vs-Grade 2 |
1.839950E-01 |
| Grade 1-vs-Grade 3 |
3.427000E-01 |
| Grade 1-vs-Grade 4 |
4.873000E-01 |
| Grade 2-vs-Grade 3 |
6.086000E-01 |
| Grade 2-vs-Grade 4 |
8.620700E-03 |
| Grade 3-vs-Grade 4 |
1.935950E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.79616346638068E-13 |
| Normal-vs-ccB subtype |
1.56541446472147E-14 |
| ccA subtype-vs-ccB subtype |
5.399600E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.46549439250521E-14 |
| Normal-vs-N1 |
1.702430E-03 |
| N0-vs-N1 |
6.468300E-02 |
|
|
